Abstract
Objective To explore the influence of Mitomycin C(MMC)in artificial nasolacrimal stent placement to treat chronic dacryocystitis.Methods 89 cases(98 eyes)of chronic dacryocystitis were divided into Mitomycin C group and control group.In the former,0.5 mL of MMC(0.02%)Was injected into the lacrimal duct during the operation and postoperation,and the latter with no MMC.Results All cases were followed-up for 10～12 months in the postopemtion.Lacrimal drainage systems were patent in 35/36 eyes in MMC group,and 53/62 eyes in control group.There Was a statistically significant difference between MMC group and control group(P=0.004,Fisher's Exact Test).Conclusion MMC in artificial nasolacrimal stent placement postoperafively seems a safe and effective adjuvant procedure and can maintain higher long-term Success rate. Key words: Mitomycin C; Nasolacrimal duct; Artificial; Implatation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Chinese Journal of Ocular Trauma and Occupational Eye Disease
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
